RNA G-quadruplexes forming scaffolds for alpha-synuclein aggregation lead to progressive neurodegeneration
Synucleinopathies, including Parkinsons disease, dementia with Lewy bodies, and multiple system atrophy, are triggered by the aggregation of -synuclein, leading to progressive neurodegeneration1,2,3,4,5,6,7,8. However, the intracellular mechanism of -synuclein aggregation remains unclear. Here we show that assembly of RNA G-quadruplexes forming scaffolds for -synuclein aggregation, contributing to neurodegeneration. Purified -synuclein binds RNA G-quadruplexes directly through the N-terminus. RNA G-quadruplex itself undergoes phase separation and assembly by Ca2+, accelerating the sol-gel phase transition of -synuclein. In -synuclein preformed fibrils-treated neurons, RNA G-quadruplexes assembly composed of synaptic mRNAs co-aggregates with -synuclein upon Ca2+ excess influx into cytoplasm, eliciting synaptic dysfunction. Forced assembly of RNA G-quadruplexes using an optogenetic approach evokes -synuclein aggregation, neuronal dysfunction and neurodegeneration. Administration of 5-aminolevulinic acid, a prodrug of protoporphyrin IX that prevents phase separation of RNA G-quadruplexes9, attenuating -synuclein aggregation, neurodegeneration, and progressive motor deficits in -synuclein preformed fibrils-injected synucleinopathy mice. Together, assembly of RNA G-quadruplexes due to dysregulation of intracellular Ca2+ homeostasis accelerates -synuclein phase transition and aggregation may contribute to pathogenesis of synucleinopathies.